– AB126 is an unmodified exosome derived from neural stem cells with the innate ability to cross the blood-brain-barrier and provide potential therapeutic benefit for multiple neurological indications –
BOSTON and ATHENS, Ga., Aug. 15, 2023 (GLOBE NEWSWIRE) — Aruna Bio, Inc., a leader in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today announced an oral presentation at the Exosome Based Therapeutic Development Summit, being held in Boston, MA from September 5-7, 2023 as well as the Applications of Exosomes as part of the BioProcess International Conference & Exhibition, being held in Boston from September 18-21, 2023. Proof-of-concept data from lead program, AB126 will be featured in two podium presentations highlighting the treatment opportunities of neural exosomes. AB126 is an unmodified neural-derived exosome with the innate ability to cross the blood-brain barrier and provide potential therapeutic benefit in its native form for multiple neurological indications.
Conference and presentation details are as follows:
Exosome Based Therapeutic Development Summit
Applications of Exosomes BioProcess International Conference & Exhibition
About Aruna Bio
Aruna Bio is a leader in the development of neural exosomes for the treatment of neurodegenerative diseases. The company is utilizing its proprietary neural exosome platform and manufacturing capability to develop a pipeline of neural exosome-based therapeutics able to cross the blood brain barrier and enhance the body’s anti-inflammatory, self-repair and protective mechanisms to treat a range of neurodegenerative disorders where significant unmet medical need exists today. Additionally, the company’s neural exosome platform can be combined with therapeutics, such as small molecules, siRNAs and proteins, to cross the blood brain barrier and to the site of disease.
Investor Contact:
Corey Davis, Ph.D.
LifeSci Advisors
212-915-2577
cdavis@lifesciadvisors.com
Ottawa, Ontario--(Newsfile Corp. - June 26, 2025) - As the Canadian Institute of Actuaries (CIA)…
PORTER WELCOMES A SEASONED LEADER TO ADVANCE MEMBER EXPERIENCE NATIONWIDE BALTIMORE, June 26, 2025 /PRNewswire/…
Novo Nordisk announces collaboration with WeightWatchers to offer patients living with obesity access to FDA-approved…
SAN DIEGO, June 26, 2025 /PRNewswire/ -- Invetech, a global leader in solving complex manufacturing…
New research reveals that subtle response-time biomarkers—captured in minutes via digital assessments—can flag Alzheimer's and…
WarrantyTracker takes explant management to the next level -- expanding beyond warranty claims to support…